Last reviewed · How we verify
NCT03835962
Development of a Reference Interval Database With the NeuroCatch™ Platform
NA trial testing NeuroCatch™ Platform in Brain Health in 135 participants. Completed in 31 January 2020.
31 January 2020
Quick facts
| Lead sponsor | NeuroCatch Inc. |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 135 |
| Start date | 1 March 2019 |
| Primary completion | 31 January 2020 |
| Estimated completion | 31 January 2020 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- NeuroCatch™ Platform
Conditions studied
- Brain Health — all drugs for Brain Health →
Sponsor
NeuroCatch Inc.
Who can join
8 and older, any sex, with Brain Health. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The NeuroCatch Platform™, an investigational medical device system developed by NeuroCatch Inc., consists of software and hardware that captures brain health information. The platform intends to provide a quick, portable and easy to use solution for the acquisition, display, analysis, storage, reporting and management of electroencephalograph (EEG) and event-related potential (ERP; brain response to a stimulus) information. The purpose of the study is to understand how the brain responds to sounds and words, and how this response varies between individuals of different age groups. Interindividual variation reflects the many different factors which cause results to vary from one individual to another within a population. The current clinical study aims to establish a reference interval database of ERPs. These reference intervals will characterize the expected range of interindividual variability between groups. Reference interval databases provide a tool for comparing the results from one individual with those from other members of the same age group.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03835962
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of NeuroCatch™ Platform
Trials testing the same drug.
- NCT03889483 — Neurophysiological Measurements Using the NeuroCatch™ Platform in Pediatric Concussion · NA · unknown
Other recruiting trials for Brain Health
Currently open trials in the same condition.
- NCT07457138 — Lombard Cohort of Brain Health Services · recruiting
- NCT05912556 — Brain Response to an Intervention Using Guided, At-Home Technology for the Mind · NA · active not recruiting
- NCT06683248 — The Effects of Night Shift Work on Health Across the Menstrual Cycle · NA · recruiting
Other NeuroCatch Inc. trials
Trials by the same sponsor.
- NCT05560620 — Sleep Deprivation Study · NA · completed
- NCT04956172 — Assessing the Impact of the NeuroCatch Platform 2 Stimulus Tone Volume · NA · completed
- NCT04661592 — NCP 2.0 Repeat Study · NA · completed
- NCT03438851 — Assessing Brain Changes Throughout the ABI Wellness Program · NA · terminated
- NCT03421405 — Assessing Repeatability of NeuroCatch Platform™ Measurements: An Initial Assessment · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03835962 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by NeuroCatch Inc.
- Last refreshed: 18 March 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03835962.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing